Laboratory of America Holdings Cyclically Adjusted PS Ratio Historical Data
The historical data trend for Laboratory of America Holdings's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratory of America Holdings Cyclically Adjusted PS Ratio Chart
|
Laboratory of America Holdings Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Cyclically Adjusted PS Ratio |
|
Get a 7-Day Free Trial
|
|
|
1.70 |
1.84 |
2.47 |
1.65 |
1.71 |
|
Laboratory of America Holdings Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Cyclically Adjusted PS Ratio |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
1.55 |
1.60 |
1.52 |
1.71 |
1.62 |
Competitive Comparison of Laboratory of America Holdings's Cyclically Adjusted PS Ratio
For the Diagnostics & Research subindustry, Laboratory of America Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratory of America Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Laboratory of America Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Laboratory of America Holdings's Cyclically Adjusted PS Ratio falls into.
Laboratory of America Holdings Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Laboratory of America Holdings's Cyclically Adjusted PS Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratory of America Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Laboratory of America Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:
| Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
| = | 37.504 | / | 129.4194 | * | 129.4194 |
| = | 37.504 |
Current CPI (Mar. 2024) = 129.4194.
Laboratory of America Holdings Quarterly Data
|
Revenue per Share |
CPI |
Adj_RevenuePerShare |
| 201406 |
17.571 |
100.560 |
22.614 |
| 201409 |
17.940 |
100.428 |
23.119 |
| 201412 |
17.569 |
99.070 |
22.951 |
| 201503 |
19.117 |
99.621 |
24.835 |
| 201506 |
22.138 |
100.684 |
28.456 |
| 201509 |
22.520 |
100.392 |
29.032 |
| 201512 |
22.270 |
99.792 |
28.882 |
| 201603 |
22.813 |
100.470 |
29.386 |
| 201606 |
23.350 |
101.688 |
29.718 |
| 201609 |
23.019 |
101.861 |
29.247 |
| 201612 |
22.366 |
101.863 |
28.417 |
| 201703 |
23.142 |
102.862 |
29.117 |
| 201706 |
24.380 |
103.349 |
30.530 |
| 201709 |
25.279 |
104.136 |
31.417 |
| 201712 |
26.417 |
104.011 |
32.870 |
| 201803 |
27.546 |
105.290 |
33.859 |
| 201806 |
27.828 |
106.317 |
33.875 |
| 201809 |
27.569 |
106.507 |
33.500 |
| 201812 |
27.572 |
105.998 |
33.664 |
| 201903 |
28.052 |
107.251 |
33.850 |
| 201906 |
29.167 |
108.070 |
34.929 |
| 201909 |
29.791 |
108.329 |
35.591 |
| 201912 |
30.137 |
108.420 |
35.974 |
| 202003 |
29.051 |
108.902 |
34.524 |
| 202006 |
28.340 |
108.767 |
33.721 |
| 202009 |
39.716 |
109.815 |
46.806 |
| 202012 |
45.674 |
109.897 |
53.788 |
| 202103 |
42.249 |
111.754 |
48.927 |
| 202106 |
39.111 |
114.631 |
44.157 |
| 202109 |
41.839 |
115.734 |
46.786 |
| 202112 |
11.125 |
117.630 |
12.240 |
| 202203 |
41.485 |
121.301 |
44.261 |
| 202206 |
31.545 |
125.017 |
32.656 |
| 202209 |
31.607 |
125.227 |
32.665 |
| 202212 |
32.844 |
125.222 |
33.945 |
| 202303 |
42.448 |
127.348 |
43.139 |
| 202306 |
34.047 |
128.729 |
34.230 |
| 202309 |
35.136 |
129.860 |
35.017 |
| 202312 |
35.477 |
129.419 |
35.477 |
| 202403 |
37.504 |
129.419 |
37.504 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Laboratory of America Holdings (Laboratory of America Holdings) Business Description
Traded in Other Exchanges
Address
358 South Main Street, Burlington, NC, USA, 27215
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Executives
| Peter J Wilkinson |
officer: SVP, Chief Accounting Officer |
C/O PHARMACEUTICAL PRODUCT DEVELOPMENT, 929 NORTH FRONT STREET, WILMINGTON NC 28401 |
| Kerrii B Anderson |
director |
WENDY'S INTERNATIONAL, INC, 4288 WEST DUBLIN-GRANVILLE RD., DUBLIN OH 43017 |
| Van Der Vaart Sandra D |
officer: SVP, Global General Counsel |
531 SOUTH SPRING STREET, BURLINGTON NC 27215 |
| Paul Rothman |
director |
6 MEADOW ROAD, BALTIMORE MD 21212 |
| Paul R Kirchgraber |
officer: CEO, Covance Drug Development |
531 SOUTH SPRING STREET, BURLINGTON NC 27215 |
| Mark S Schroeder |
officer: EVP, President-Diagnostics Lab |
531 SOUTH SPRING STREET, BURLINGTON NC 27215 |
| Megan D. Bailey |
officer: EVP, Chief Strategy Officer |
531 SOUTH SPRING STREET, BURLINGTON NC 27215 |
| Jonathan P. Divincenzo |
officer: EVP, Pres, Central Labs & Intl |
940 WINTER STREET, PERKINELMER, INC. LEGAL DEPARTMENT, WALTHAM MA 02451 |
| Anita Z Graham |
officer: EVP, CHRO |
C/O THE ADT CORPORATION, 1501 YAMATO ROAD, BOCA RATON FL 33431 |
| Thomas Pike |
officer: Pres & CEO Clinical Business |
C/O ACCENTURE, 161 N. CLARK STREET, 23RD FLOOR, CHICAGO IL 60601 |
| Kirsten Marie Kliphouse |
director |
531 SOUTH SPRING STREET, BURLINGTON NC 27215 |
| Glenn A Eisenberg |
officer: Chief Financial Officer, EVP |
P O BOX 1017, CHARLOTTE NC 28201-1017 |
| Brian J Caveney |
officer: SVP, Chief Medical Officer |
531 SOUTH SPRING STREET, BURLINGTON NC 27215 |
| R Sanders Williams |
director |
DUKE UNIVERSITY SCHOOL OF MEDICINE, TRENT DRIVE, DURHAM NC 27706 |
| Amy B. Summy |
officer: EVP, Chief Marketing Officer |
531 SOUTH SPRING STREET, BURLINGTON NC 27215 |
Laboratory of America Holdings (Laboratory of America Holdings) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LH has been successfully added to your